Company Profiles

driven by the PitchBook Platform

OptiNose

Description

Developer of exhalation delivery systems designed to improve quality of life for patients by providing better alternatives to existing treatments, including prescription medications, vaccines, biologics and over-the-counter medications. The company's OptiNose platform uses Exhalation Delivery Systems (EDS) that produce high and deep intranasal deposition of medication, enabling medical person to deliver liquid and powder formulations through multi-use nasal devices.

2000

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$37M

Latest Deal Amount

$164M

Total Amount Raised

Description

Developer of exhalation delivery systems designed to improve quality of life for patients by providing better alternatives to existing treatments, including prescription medications, vaccines, biologics and over-the-counter medications. The company's OptiNose platform uses Exhalation Delivery Systems (EDS) that produce high and deep intranasal deposition of medication, enabling medical person to deliver liquid and powder formulations through multi-use nasal devices.

Website:

www.optinose.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Other Devices and Supplies

Primary Office

1020 Stony Hill Road 3rd Floor (Suite 300) Yardley, PA 19067United States +1 (267) 364-3500
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore OptiNose's full profile, request a free trial.

OptiNose Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

OptiNose Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

OptiNose Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Avista Capital PartnersPE/BuyoutMinority000 0000000 0000
Entrepreneurs FundFamily OfficeMinority000 0000000 0000
Fidelity Management & ResearchOtherMinority000 0000000 0000
InSpire GroupVenture CapitalMinority000 0000000 0000
Research Council of NorwayGovernment000 0000000 0000
Avista Capital Partners PE/Buyout
Entrepreneurs Fund Family Office
Fidelity Management & Research Other
InSpire Group Venture Capital
Research Council of Norway Government

OptiNose Executive Team (16)

NameTitleBoard
Seat
Contact
Info
Helena DjupeslandCo-Founder and Co-Chief Executive Officer of OptiNose AS (Norway)
Peter MillerChief Executive Officer & Board Member
Ramy Mahmoud MDPresident & Chief Operating Officer
Keith GoldanChief Financial Officer
Tammy MccauleyChief Administrative Officer
Helena Djupesland Co-Founder and Co-Chief Executive Officer of OptiNose AS (Norway)
Peter Miller Chief Executive Officer & Board Member
Ramy Mahmoud MD President & Chief Operating Officer
Keith Goldan Chief Financial Officer
Tammy Mccauley Chief Administrative Officer

OptiNose Board Members (9)

NameRepresentingRoleSinceContact
Info
Jackson PhillipsAvista Capital PartnersFounding Member & Principal000 0000
Joshua TamaroffAvista Capital PartnersVice President000 0000
Klaas de BoerEntrepreneurs FundManaging Partner000 0000
Larry PickeringOptiNoseBoard Member000 0000
Patrick O'Neill Ph.DAvista Capital PartnersOperating Executive000 0000
Jackson Phillips Founding Member & Principal Avista Capital Partners
Joshua Tamaroff Vice President Avista Capital Partners
Klaas de Boer Managing Partner Entrepreneurs Fund
Larry Pickering Board Member OptiNose
Patrick O'Neill Ph.D Operating Executive Avista Capital Partners
Request full access to PitchBook